Document Detail


Genetic ancestry and risk factors for breast cancer among Latinas in the San Francisco Bay Area.
MedLine Citation:
PMID:  17035394     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Genetic association studies using case-control designs are susceptible to false-positive and false-negative results if there are differences in genetic ancestry between cases and controls. We measured genetic ancestry among Latinas in a population-based case-control study of breast cancer and tested the association between ancestry and known breast cancer risk factors. We reasoned that if genetic ancestry is associated with known breast cancer risk factors, then the results of genetic association studies would be confounded.
METHODS: We used 44 ancestry informative markers to estimate individuals' genetic ancestry in 563 Latina participants. To test whether ancestry is a predictor of hormone therapy use, parity, and body mass index (BMI), we used multivariate logistic regression models to estimate odds ratios (OR) and 95% confidence intervals (95% CI) associated with a 25% increase in Indigenous American ancestry, adjusting for age, education, and the participant's and grandparents' place of birth.
RESULTS: Hormone therapy use was significantly less common among women with higher Indigenous American ancestry (OR, 0.78; 95% CI, 0.63-0.96). Higher Indigenous American ancestry was also significantly associated with overweight (BMI, 25-29.9 versus <25) and obesity (BMI, > or =30 versus <25), but only among foreign-born Latina women (OR, 3.44; 95% CI, 1.97-5.99 and OR, 1.95; 95% CI, 1.24-3.06, respectively).
CONCLUSION: Some breast cancer risk factors are associated with genetic ancestry among Latinas in the San Francisco Bay Area. Therefore, case-control genetic association studies for breast cancer should directly measure genetic ancestry to avoid potential confounding.
Authors:
Elad Ziv; Esther M John; Shweta Choudhry; Jennifer Kho; Wendy Lorizio; Eliseo J Perez-Stable; Esteban Gonzalez Burchard
Related Documents :
10850134 - The epidemiology of her-2/neu and p53 in breast cancer.
19444084 - Breast cancer risk perception and lifestyle behaviors among white and black women with ...
19009364 - Breast cancer risk and hysterectomy status: the multiethnic cohort study.
15996484 - Hormonal and body-size factors in relation to breast cancer risk: a prospective study o...
12223434 - Genetic polymorphism of cyp2a6 gene and tobacco-induced lung cancer risk in male smokers.
2910524 - Neuroendocrine dysdifferentiation and bombesin production in carcinogen-induced hepatoc...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.    
Journal Detail:
Title:  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology     Volume:  15     ISSN:  1055-9965     ISO Abbreviation:  Cancer Epidemiol. Biomarkers Prev.     Publication Date:  2006 Oct 
Date Detail:
Created Date:  2006-10-12     Completed Date:  2007-06-20     Revised Date:  2011-11-29    
Medline Journal Info:
Nlm Unique ID:  9200608     Medline TA:  Cancer Epidemiol Biomarkers Prev     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1878-85     Citation Subset:  IM    
Affiliation:
Division of General Internal Medicine, University of California San Francisco, Box 1732, San Francisco, CA 94143, USA. elad.ziv@ucsf.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
African Americans / genetics
Aged
Aged, 80 and over
Breast Neoplasms / ethnology*,  etiology*,  genetics
Case-Control Studies
Emigration and Immigration
European Continental Ancestry Group / genetics
Female
Genetic Markers
Genetic Predisposition to Disease / ethnology
Genotype
Hispanic Americans / genetics*,  statistics & numerical data
Humans
Logistic Models
Middle Aged
Multivariate Analysis
Obesity / complications,  ethnology
Population Surveillance
Predictive Value of Tests
Risk Assessment
Risk Factors
San Francisco / epidemiology
Grant Support
ID/Acronym/Agency:
K22 CA109351-03/CA/NCI NIH HHS; K22CA109351/CA/NCI NIH HHS; R01 CA063446-04/CA/NCI NIH HHS; R01 CA077305-03/CA/NCI NIH HHS; U01 CA069417-10/CA/NCI NIH HHS
Chemical
Reg. No./Substance:
0/Genetic Markers

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  General and abdominal obesity and survival among young women with breast cancer.
Next Document:  Increases in plasma carotenoid concentrations in response to a major dietary change in the women's h...